Evidence map›Paper›PMID 30918171›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Crohn's Disease Accompanied with Small Intestinal Extramedullary Plasmacytoma.

Yoshinori Hanawa, Masaaki Higashiyama, Kazuki Horiuchi, Kana Ayaki, Suguru Ito, Akinori Mizoguchi, Shin Nishii, Akinori Wada, Kenichi Inaba, Nao Sugihara and 12 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Yoshinori HanawaDepartment of Internal Medicine, National Defense Medical College, Japan.
Masaaki HigashiyamaDepartment of Internal Medicine, National Defense Medical College, Japan.
Kazuki HoriuchiDepartment of Internal Medicine, National Defense Medical College, Japan.
Kana AyakiDepartment of Internal Medicine, National Defense Medical College, Japan.
Suguru ItoDepartment of Internal Medicine, National Defense Medical College, Japan.
Akinori MizoguchiDepartment of Internal Medicine, National Defense Medical College, Japan.
Shin NishiiDepartment of Internal Medicine, National Defense Medical College, Japan.
Akinori WadaDepartment of Internal Medicine, National Defense Medical College, Japan.
Kenichi InabaDepartment of Internal Medicine, National Defense Medical College, Japan.
Nao SugiharaDepartment of Internal Medicine, National Defense Medical College, Japan.
Hirotaka FuruhashiDepartment of Internal Medicine, National Defense Medical College, Japan.
Takeshi TakajoDepartment of Internal Medicine, National Defense Medical College, Japan.
Kazuhiko ShirakabeDepartment of Internal Medicine, National Defense Medical College, Japan.
Chikako WatanabeDepartment of Internal Medicine, National Defense Medical College, Japan.
Kengo TomitaDepartment of Internal Medicine, National Defense Medical College, Japan.
Shunsuke KomotoDepartment of Internal Medicine, National Defense Medical College, Japan.
Shigeaki NagaoDepartment of Internal Medicine, National Defense Medical College, Japan.
Soichiro MiuraDepartment of Internal Medicine, National Defense Medical College, Japan.
Hideyuki ShimazakiDepartment of Laboratory Medicine, National Defense Medical College Hospital, Japan.
Kengo TakeuchiPathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Japan.
Hideki UenoDepartment of Surgery, National Defense Medical College, Japan.
Ryota HokariDepartment of Internal Medicine, National Defense Medical College, Japan.
National Defense Medical College · JPJapanese Foundation For Cancer Research · JPNational Defense Medical College Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein present the case of an immunocompetent 63-year-old man who had previously undergone resection of Crohn's disease (CD)-related small intestinal obstruction more than 30 years ago. He had not been receiving any medication for many years, but had recently started to suffer from ileus. A stenosed site of ileo-cecal anastomosis was identified and therefore was surgically resected, which was diagnosed as CD with small intestinal extramedullary plasmacytoma (EMP). The subsequent progression of CD was successfully controlled by anti-TNFα agents without any recurrence of EMP for over 3 years, implying the clinical benefit and safety of the biological therapy. This was the first known case of a patient who received anti-TNFα agents after a resection of small intestinal EMP accompanied with CD.

Indexed as

Antineoplastic AgentsCrohn DiseaseGastrointestinal AgentsHumansIntestine, SmallJapanMaleMiddle AgedNeoplasm Recurrence, LocalPlasmacytomaTreatment OutcomeTumor Necrosis Factor-alphaAntineoplastic AgentsGastrointestinal AgentsTumor Necrosis Factor-alphaanti-TNFα agentsCrohn's disease (CD)extramedullary plasmacytoma (EMP)plasmablastic lymphoma (PBL)plasmablastic neoplasm

Identifiers

PMID30918171
PMCPMC6702015
OpenAlexW2924454546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.